Seminars in Liver Disease

Papers
(The H4-Index of Seminars in Liver Disease is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Expert Practical Recommendations for Hepatocellular Carcinoma100
Hepatic Extracellular Matrix and Its Role in the Regulation of Liver Phenotype38
A Precision Medicine Guided Approach to the Utilization of Biomarkers in MASLD35
Tight Junction Proteins as Therapeutic Targets to Treat Liver Fibrosis and Hepatocellular Carcinoma35
Critical Care Management of Acute-on-Chronic Liver Failure: Certainties and Unknowns29
Patient-Reported Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease26
Genetic and Epigenetic Basis of Drug-Induced Liver Injury26
HBV Biomarkers and Their Role in Guiding Treatment Decisions23
Tailored Model of Care for Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease23
Emerging Targets for the Treatment of Primary Sclerosing Cholangitis22
Genetic Contributions to Biliary Atresia: A Developmental Cholangiopathy21
Growth Hormone Signaling in Liver Diseases: Therapeutic Potentials and Controversies19
Physiomimetic In Vitro Human Models for Viral Infection in the Liver18
Alcohol Plus Additional Risk Factors: Rodent Model of Liver Injury18
Wilson Disease: Novel Diagnostic and Therapeutic Approaches17
Diagnosis and Management of Early Stages of ALD16
Mice Engrafted with Human Liver Cells16
0.086976051330566